Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P71
Within normal range
vs 2Y Ago
0.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20257.20%
Q3 20257.74%
Q2 202510.32%
Q1 20253.23%
Q4 20244.55%
Q3 20242.37%
Q2 20244.38%
Q1 2024-1.26%
Q4 20238.96%
Q3 2023-0.26%
Q2 20239.36%
Q1 2023-3.66%
Q4 2022-0.06%
Q3 2022118.43%
Q2 2022-8.83%
Q1 2022-0.79%
Q4 2021-7.93%
Q3 2021-9.44%
Q2 2021-10.27%
Q1 2021-10.96%
Q4 2020-9.09%
Q3 202041.62%
Q2 202020.05%
Q1 2020-11.17%
Q4 2019-9.68%
Q3 2019-8.55%
Q2 2019-10.98%
Q1 20197.51%
Q4 2018-7.24%
Q3 2018-4.94%
Q2 201862.44%
Q1 2018373.29%
Q4 20170.00%
Q3 20170.00%
Q2 20170.00%
Q1 20170.00%